BioAdaptives, Inc.
BDPT
$0.0653
-$0.0147-18.38%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -55.44% | -21.34% | 173.08% | 147.33% | 66.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -55.44% | -21.34% | 173.08% | 147.33% | 66.67% |
| Cost of Revenue | 408.47% | 483.33% | 600.00% | 212.66% | 75.25% |
| Gross Profit | -809.17% | -910.87% | -252.31% | 73.61% | 53.52% |
| SG&A Expenses | 138.56% | 48.14% | 33.91% | -0.53% | -42.31% |
| Depreciation & Amortization | -93.26% | -122.42% | 334.85% | -1.01% | -54.66% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 131.64% | 49.34% | 63.41% | 5.43% | -41.33% |
| Operating Income | -155.13% | -58.69% | -55.58% | 2.59% | 45.75% |
| Income Before Tax | -26.19% | -68.38% | -4.81% | 10.25% | 20.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.19% | -68.38% | -4.81% | 10.25% | 20.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.19% | -68.38% | -4.81% | 10.25% | 20.44% |
| EBIT | -155.13% | -58.69% | -55.58% | 2.59% | 45.75% |
| EBITDA | -218.26% | -93.48% | -34.38% | 10.34% | 49.17% |
| EPS Basic | 47.63% | 56.28% | 85.77% | 89.74% | 88.47% |
| Normalized Basic EPS | 43.33% | 45.40% | 89.47% | 91.75% | 89.61% |
| EPS Diluted | 47.63% | 56.28% | 85.77% | 89.74% | 88.47% |
| Normalized Diluted EPS | 43.33% | 45.40% | 89.47% | 91.75% | 89.61% |
| Average Basic Shares Outstanding | 19.15% | 200.94% | 378.99% | 596.42% | 789.44% |
| Average Diluted Shares Outstanding | 19.15% | 200.94% | 378.99% | 596.42% | 789.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |